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Abstract
Background: Several previous epidemiological studies have shown a relation between drinking
water quality and death in cardiovascular disease whereas others have not found such a
relationship. An intervention study was undertaken to evaluate the effect of water with added
magnesium and natural mineral water on blood pressure.
Methods: A group of 70 subjects with borderline hypertension was recruited and consumed 1) a
water low in minerals, 2) magnesium enriched water or 3) natural mineral water, in a random,
double blind fashion during four weeks.
Results: Among persons with an initial low excretion of magnesium or calcium in the urine, the
urinary excretion of magnesium was increased in the groups consuming the two waters containing
magnesium after 4 weeks. A significant decrease in blood pressure was found in the group
consuming mineral water at 2 and 4 weeks.
Conclusion: The results suggest that minerals taken in water are significant for the body burden
and that an intake of mineral water among persons with a low urinary excretion of magnesium or
calcium may decrease the blood pressure. Further studies should investigate the extent of mineral
deficiency in different populations and the efficiency of different vehicles for supplying minerals,
particularly magnesium and calcium.
Background
A relation between mortality from ischaemic heart disease
(IHD) and drinking water characteristics was first shown
in Japan in 1957 [1]. Since then, several studies have dem-
onstrated the same relationships, one of the last being a
study from Finland in 2004 [2] and reviews have been
presented [3,4]. Other studies have, however, not found
such relationships or only weak associations between
mineral intake and risk for cardiovascular disease [5,6].
This discrepancy may be due to an absence of causality or
to variations in the populations studied regarding intake
of minerals.
In a case-control study, an inverse relation was found
between the amount of magnesium in drinking water and
death from acute myocardial infarction and for females
also between the amount of calcium and death [7]. Diets
rich in vegetables and fruit, which contain high amounts
of minerals, had a protective effect on cardiovascular dis-
ease [8,9]. This suggests that the mineral balance in
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individuals depends on different types of intakes which
may vary depending on geographical and socio-economi-
cal conditions.
Regarding individual minerals, several studies have been
reported where hypertensive subjects were treated orally
with nutritional doses of magnesium [10]. The results sug-
gested a dose-dependent reduction in blood pressure
from the magnesium intervention but it was concluded
that the relationship must be confirmed in larger studies,
using higher doses of magnesium. A similar meta-analysis
reported a very small effect of calcium supplementation
[11]. A meta-analysis of 33 studies on potassium interven-
tion concluded that there might be a beneficial effect on
blood pressure [12]. Many of the studies reviewed were,
however, dietary intervention studies, and the interven-
tion thus comprised several minerals and other agents
rather than potassium alone.
Epidemiological studies on cardiovascular disease suggest
that drinking water is an important vehicle for the supply
of minerals [7]. This is supported by data from short-term
intervention studies using mineral water, as well as an epi-
demiological study [13-15].
The present intervention study was undertaken to deter-
mine the effect of minerals in water on one of the major
risk factors for cardiovascular disease – blood pressure.
Subjects with slightly elevated blood pressure consumed
water with different levels of minerals. Serum and urinary
levels of minerals were measured as a marker of interven-
tion and blood pressure was measured before and after
the intervention.
Methods
Subjects
Female and male subjects, aged 45 – 64 years (n = 70)
were recruited by advertising in local newspapers. Inclu-
sion criteria were living in an area with low magnesium
content in the drinking water, systolic pressure 15 mm
above normal values for their age, diastolic pressure above
90 mm Hg, and within 20% of ideal body weight. Exclu-
sion criteria were hypertension target organ damage,
chronic diseases (heart, liver, kidney, diabetes mellitus),
pregnancy, and taking oral contraceptives or regular
intake of mineral supplements. Subjects with a diastolic
pressure above 100 mm Hg were advised to consult a phy-
sician for treatment. A few persons decided not to seek a
physician's advice and choose to participate anyway. The
Ethical committee at the Medical faculty, University of
Gothenburg, approved the study.
Blood pressure
Blood pressure was measured using standardized tech-
niques before the intervention, at 2 weeks and at the end
at 4 weeks. Two separate recordings were made (diastolic
pressure as Korothoff phase 5) after 5 minutes of supine
rest. The blood pressure is reported as the average of these
recordings.
Blood and urine samples
Blood samples were taken before and after the interven-
tion to determine the serum concentration of magnesium,
calcium, sodium, creatinine and potassium (analysis per-
formed at the accredited laboratory for Clinical Chemis-
try, Sahlgren's Hospital, Gothenburg). Before and after the
intervention period, 24 hours urine samples were col-
lected and the amounts of magnesium, calcium, and cre-
atinine were determined (idem). Magnesium and calcium
levels in urine were expressed as the creatinine ratio.
Intervention
The participants were randomly allotted into three groups
to which the three waters were supplied in similar bottles
marked A, B and C. The composition of the waters (see
Table 1) was unknown to the persons engaged in the
intervention study. The subjects were asked to consume at
least one liter of water/day. When preparing coffee and
tea, ordinary tap water could be used. There were no diffi-
culties in consuming the allotted quantity and spot checks
were made to control for the proper consumption. The
intervention lasted 4 weeks. None of the subjects changed
their normal dietary habits during the trial.
Statistical evaluation
The three groups were compared using the Student's t-test
for paired samples and p < 0.05 was considered statisti-
cally significant. For a smaller subgroup of 6 individuals,
comparisons were made using the Wilcoxon test for pairs.
Results
In the analysis of the whole group, no differences in any
parameters were found between persons consuming the
Table 1: Composition of the three waters used in the 
intervention study. (1)Valvert®; (2)Distilled water+MgSO4; 
(3)Contrex®.
Waters Minerals/mg L A1 B2 C3
Calcium (Ca2+)6 7 . 6 4 4 8 6
Magnesium (Mg2+) 2 82.3 84
Sodium (Na+) 1.9 2.4 9.1
Potassium (K+) 0.2 0.1 3.2
Sulphate (SO4
2-) 18 326 1187
Bicarbonate (HCO3
-)2 0 4 1 2 4 0 3
Chloride (Cl-)4 0 . 7 8 . 6
Fluoride (F-)0 <0.05 0 0.32
Silica (SiO2)5 . 7 0 8BMC Public Health 2004, 4:56 http://www.biomedcentral.com/1471-2458/4/56
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different types of water. For the subsequent analysis, sub-
jects with serum or urine values in excess of the 75 percen-
tile were excluded on the ground that these represented a
group with a sufficient body burden of the minerals and
would not be influenced by the intervention. For magne-
sium in urine, this value was 0.39 mmol/l, and for cal-
cium 0.50 mmol/L. For magnesium, calcium, potassium
and sodium in blood the values were 0.9, 2.4, 4.4 and 141
mmol/L, respectively.
There was a close relation between the amount of cal-
cium/creatinine and magnesium/creatinine in the urine
before the intervention (p = 0.001). Table 2 shows the
amounts of calcium and magnesium in urine before and
after the intervention with different kinds of waters. It is
seen that persons consuming waters B and C had signifi-
cantly higher amounts of magnesium in the urine after the
intervention. No significant effects of the waters on serum
levels of magnesium could be detected (data not shown).
Table 3 shows the blood pressure before and after inter-
vention. Among persons consuming water C, both the
systolic and diastolic blood pressures decreased signifi-
cantly at 2 and 4 weeks. A similar result was obtained
when the group with an initial low level of calcium in the
urine was evaluated (data not shown).
In spite of the random allocation to the different waters, it
was found that the group consuming water C comprised a
larger number of persons with a high initial systolic pres-
sure. In the groups receiving waters A and B, none of the
subjects had systolic blood pressures above 170 before the
intervention. The subjects drinking water C were divided
into those with an initial systolic pressure above and
below 170 mm. For the group with the higher pressure (n
= 6), there was a decrease in the systolic pressure before
and at 4 weeks (p = 0.023) but no difference at 2 weeks or
for diastolic pressure. The results from the remainder of
the group are also shown in Table 3. It is seen that
significant reductions were observed both for systolic and
diastolic blood pressure after 2 and 4 weeks.
Discussion
The study is of exploratory character, based on a relatively
small number of subjects and should be interpreted with
care. There is also a lack of some data that retrospectively
Table 2: Magnesium/creatinine and calcium/creatinine in urine (mmol/L) among subjects with an initial level less than 0.40 mmol/L 
magnesium before and after intervention with different waters.
Water n Before After p
Magnesium
A 18 0.25 (0.08) 0.26 (0.07)
B 18 0.28 (0.06) 0.34 (0.09) 0.009
C 19 0.30 (0.07) 0.35 (0.09) 0.019
Calcium
A 18 0.40 (0.22) 0.35 (0.40)
B 18 0.33 (0.12) 0.35 (0.40)
C 19 0.34 (0.13) 0.38 (0.16)
Table 3: Blood pressure among subjects with an initial magnesium level in urine less than 0.40 mmol/L before and after intervention 
with different waters. * denotes group with initial systolic values below 170 mm (see text).
Water n Before 2 weeks 4 weeks
Systolic
A 18 151.9 (9.8) 154.2 (15.9) 148.3 (12.4)
B 18 148.3 (10.5) 146.8 (13.6) 147.9 (11.5)
C 19 156.8 (15.9) 150.1(16.1)p = 0.034 150.4(15.5)p = 0.017
C* 13 148.8 (13.3) 142.5(10.1)p = 0.028 144.3(14.4)p = 0.047
Diastolic
A 18 90.1 (4.4) 91.2 (6.1) 89.8 (5.0)
B 18 90.4 (4.2) 89.3 (6.0) 90.9 (6.6)
C 19 91.7 (6.3) 88.0 (7.6) p = 0.014 89.1 (8.0) p = 0.020
C* 13 91.3 (6.4) 87.3 (6.3) p = 0.004 88.1 (8.6) p = 0.012BMC Public Health 2004, 4:56 http://www.biomedcentral.com/1471-2458/4/56
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would have been of interest such as sodium in the urine
and the effect of water with only calcium added. We do
not think, however, that this has any influence on the
major conclusions from the study.
The intervention with the two waters with added magne-
sium influenced the body burden in terms of an increased
excretion of magnesium in urine. This is consistent with
findings from previous intervention studies [16,17]
although the dose of magnesium used here was rather low
in comparison to several previous studies [10]. It could
have been of interest to study the effect of different doses
of magnesium only, but in view of the conclusions regard-
ing the better effect of total mineral water on blood pres-
sure, this does not have a high priority. The absence of an
effect on serum was expected; it has previously been
shown that serum magnesium is a poor indicator of the
body burden or the intracellular content [18].
The intervention with water containing high amounts of
several minerals decreased the blood pressure signifi-
cantly in contrast to water with magnesium only where no
significant effect was detected. This does not exclude that
an effect could have been found with the latter water, had
the intervention time been longer. On the other hand, the
finding supports the concept that interventions should be
performed under conditions similar to the ones present in
normal environments, rather than with one specific agent.
This could also explain the lack of an effect in previous
studies where single minerals have been given as reviewed
in the introduction.
Conclusion
In summary, the results suggest that waterborne minerals
constitute a supply for the body burden, that the urinary
excretion can be used as a physiologically relevant indica-
tor of the body burden of magnesium and calcium, and
that the supplementation of magnesium together with
other minerals may reduce blood pressure among persons
with a low body burden of magnesium and calcium,
either due to an insufficient intake through food or water,
or through some metabolic/clinical disturbance. Addi-
tional studies are needed to explore this further.
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